• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The in-vitro activity of a new highly active quinolone, DU-6859a.

作者信息

Jolley A, Andrews J M, Brenwald N, Wise R

机构信息

Department of Microbiology, Dudley Road Hospital, Birmingham, UK.

出版信息

J Antimicrob Chemother. 1993 Nov;32(5):757-63. doi: 10.1093/jac/32.5.757.

DOI:10.1093/jac/32.5.757
PMID:8125840
Abstract
摘要

相似文献

1
The in-vitro activity of a new highly active quinolone, DU-6859a.新型高效喹诺酮DU-6859a的体外活性
J Antimicrob Chemother. 1993 Nov;32(5):757-63. doi: 10.1093/jac/32.5.757.
2
In vitro activities of BMS-284756 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae.BMS-284756对沙眼衣原体及肺炎衣原体近期临床分离株的体外活性
Antimicrob Agents Chemother. 2002 Feb;46(2):517-8. doi: 10.1128/AAC.46.2.517-518.2002.
3
Bactericidal activity of the new 4-quinolones DU-6859a and DV-7751a.
J Med Microbiol. 1995 Jul;43(1):4-8. doi: 10.1099/00222615-43-1-4.
4
In-vitro activity of gatifloxacin against Chlamydia trachomatis and Chlamydia pneumoniae.加替沙星对沙眼衣原体和肺炎衣原体的体外活性。
J Antimicrob Chemother. 1999 Oct;44(4):549-51. doi: 10.1093/jac/44.4.549.
5
Comparative in vitro activity of garenoxacin against Chlamydia spp.加替沙星对衣原体属的体外活性比较
J Antimicrob Chemother. 2002 Sep;50(3):407-10. doi: 10.1093/jac/dkf145.
6
In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae.新型喹诺酮类药物OPC - 17116、氧氟沙星及司帕沙星对肺炎衣原体的体外活性
Antimicrob Agents Chemother. 1994 Jun;38(6):1402-3. doi: 10.1128/AAC.38.6.1402.
7
The in-vitro activity of OPC-17116, a new 5-methyl substituted quinolone.新型5-甲基取代喹诺酮OPC-17116的体外活性
J Antimicrob Chemother. 1993 Apr;31(4):497-504. doi: 10.1093/jac/31.4.497.
8
Comparative study of the in vitro activity of a new fluoroquinolone, ABT-492.新型氟喹诺酮类药物ABT-492体外活性的比较研究
J Antimicrob Chemother. 2004 May;53(5):783-92. doi: 10.1093/jac/dkh180. Epub 2004 Mar 31.
9
In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae.新型非氟喹诺酮类抗生素奈诺沙星对沙眼衣原体和肺炎衣原体的体外活性
Antimicrob Agents Chemother. 2014;58(3):1800-1. doi: 10.1128/AAC.02263-13. Epub 2013 Dec 23.
10
In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp.新型氟喹诺酮类药物AM - 1155对衣原体属的体外和体内活性
Antimicrob Agents Chemother. 1997 Jun;41(6):1331-4. doi: 10.1128/AAC.41.6.1331.

引用本文的文献

1
Establishing Sitafloxacin Epidemiological Cut-off Values (ECOFFs) for Clinical Bacterial Isolates.确定临床细菌分离株的西他沙星流行病学临界值（ECOFFs）。
Infect Drug Resist. 2025 Apr 23;18:1993-2004. doi: 10.2147/IDR.S501783. eCollection 2025.
2
Comparative in vitro activities of DU-6859a, levofloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against 387 aerobic and anaerobic bite wound isolates.DU-6859a、左氧氟沙星、氧氟沙星、司帕沙星和环丙沙星对387株需氧和厌氧咬伤伤口分离菌株的体外比较活性。
Antimicrob Agents Chemother. 1997 May;41(5):1193-5. doi: 10.1128/AAC.41.5.1193.
3
Bactericidal activity of DU-6859a compared to activities of three quinolones, three beta-lactams, clindamycin, and metronidazole against anaerobes as determined by time-kill methodology.
通过时间杀菌法测定DU-6859a与三种喹诺酮类、三种β-内酰胺类、克林霉素和甲硝唑对厌氧菌的杀菌活性比较。
Antimicrob Agents Chemother. 1997 Apr;41(4):847-9. doi: 10.1128/AAC.41.4.847.
4
Antimicrobial activity and spectrum of LB20304, a novel fluoronaphthyridone.新型氟萘啶酮LB20304的抗菌活性及抗菌谱
Antimicrob Agents Chemother. 1997 Jan;41(1):204-11. doi: 10.1128/AAC.41.1.204.
5
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.DU-6859a、环丙沙星、左氧氟沙星、司帕沙星、头孢噻肟、亚胺培南及万古霉素对9株青霉素敏感及耐药肺炎球菌活性的最低抑菌浓度（MIC）及时间杀菌研究
Antimicrob Agents Chemother. 1996 Feb;40(2):362-6. doi: 10.1128/AAC.40.2.362.
6
Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.环丙沙星。对其药理学、治疗效果及耐受性的最新综述。
Drugs. 1996 Jun;51(6):1019-74. doi: 10.2165/00003495-199651060-00010.
7
In vitro activity of fluoroquinolones against gram-positive bacteria.氟喹诺酮类药物对革兰氏阳性菌的体外活性。
Drugs. 1995;49 Suppl 2:48-57. doi: 10.2165/00003495-199500492-00009.
8
Quinolones in sexually transmitted diseases. Global experience.喹诺酮类药物在性传播疾病中的应用。全球经验。
Drugs. 1995;49 Suppl 2:115-22. doi: 10.2165/00003495-199500492-00018.
9
Comparative microbiological activity and pharmacokinetics of cefprozil.
Eur J Clin Microbiol Infect Dis. 1994 Oct;13(10):839-45. doi: 10.1007/BF02111350.
10
New and future antibiotics in the treatment of acute respiratory tract infections.用于治疗急性呼吸道感染的新型及未来抗生素
Thorax. 1995 Mar;50(3):223-4. doi: 10.1136/thx.50.3.223.